Inspection Record

Thrifty White Drug #762 — FDA 483 Findings

US FDAInspected 2018-09-21Published 2019-04-30 6 findingsAseptic processing and sterility assuranceValidation and qualification

Inspectors Anthony J Ladner · Ross J GrigsbyThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

The ISO 5 classified aseptic processing areas had difficult to clean equipment or surface.

2Aseptic processing and sterility assurance

Disinfecting agents and cleaning wipes used in the ISO 5 classified aseptic processing areas were not sterile.

3Aseptic processing and sterility assurance

Equipment was and Materials or supplies were not disinfected prior to entering the aseptic processing areas.

4Aseptic processing and sterility assurance

Sporicidal agents were not used in your facility's cleanrooms and/or ISO 5 classified aseptic processing area.

5Validation and qualification

ISO 5 classified areas were not certified under dynamic conditions.

6Aseptic processing and sterility assurance

Media fills were not performed that closely simulate aseptic production operations incorporating, as appropriate, worst-case activities and conditions that provide a challenge to aseptic operations.

About this record

Extracted automatically from the document US FDA published on 2019-04-30. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Thrifty White Drug #762 company profile — full history US FDA documents, 2019 Go to Findings search